Biocon Biologics, RSSDI collaborate to expand access to insulins for diabetic kids Ruchika Sharma15 Nov 2021 4:12 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd., today announced that it has tied up with the Research Society for the Study of...
Biocon Biologics, Viatris interchangeable biosimilar Insulin Glargine preferred on Express Scripts' largest formulary in US Ruchika Sharma21 Oct 2021 3:28 PM ISTBengaluru: Biocon Biologics Limited, a subsidiary of Biocon Ltd. has recently announced that Express Scripts, a pharmacy benefit management...
Biocon Biologics gets 6 USFDA observations for Malaysia facility Ruchika Sharma27 Sept 2021 2:10 PM ISTBangalore: Pharma major Biocon has recently announced that the US Food and Drug Administration (USFDA) has concluded an inspection with 6 observations...
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance Ruchika Sharma17 Sept 2021 12:48 PM ISTBengaluru: Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS), a subsidiary of Serum...
Biocon Biologics, Viatris get USFDA nod for first interchangeable biosimilar Semglee for diabetes Ruchika Sharma29 July 2021 1:33 PM ISTThe interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus, at the pharmacy counter, will be...
Biocon Biologics, Adagio Therapeutics join hands to advance antibody for COVID treatment Ruchika Sharma27 July 2021 1:27 PM ISTInitial data indicate that ADG20 could provide both rapid and durable protection against COVID-19 for up to one year.
Biocon Biologics bags 2021 Facility of the Year Award Ruchika Sharma30 April 2021 11:00 AM ISTBengaluru: Biocon Biologics, a subsidiary of Biocon, has recently announced that the company has been awarded with the 2021 Facility of the Year...
Biocon Biologics, Viatris get EC approval for Abevmy Ruchika Sharma26 April 2021 3:29 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed...
Biocon Biologics appoints Susheel Umesh as CCO for emerging markets Ruchika Sharma3 March 2021 12:18 PM ISTBengaluru: Biocon Biologics, a subsidiary of Biocon has recently announced that Mr Susheel Umesh has joined Biocon Biologics as the Chief...
Biocon Biologics promotes Shreehas Tambe to Deputy CEO Ruchika Sharma2 March 2021 12:07 PM ISTBengaluru: Biocon Biologics, a subsidiary of Biocon has recently announced that Mr Shreehas Tambe has been promoted to the position of Deputy...
Biocon Biologics, Viatris get CHMP nod for Abevmy Ruchika Sharma1 March 2021 1:44 PM ISTBengaluru: Biocon Biologics, a subsidiary of Biocon announced today that the European Medicines Agency's Committee for Medicinal Products for Human...
Biocon Biologics, IDF collaborate to promote Diabetes Care, Prevention, effective management worldwide Ruchika Sharma16 Feb 2021 2:03 PM ISTBengaluru: Biocon Biologics Ltd., a subsidiary of Biocon Ltd., has announced the partnership with The International Diabetes Federation (IDF) as the...
